跳至主要内容
临床试验/NCT06229990
NCT06229990招募中4 期

Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury (FST-LIBERATE)

Chiang Mai University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
80
试验地点
1
主要终点
% of patients with Renal recovery

研究概览

简要总结

Currently, continuous renal replacement therapy (CRRT) is the main modality for renal support in critically ill patients with hemodynamic instability. Most studies have investigated the timing of RRT initiation. However, prolonged CRRT demonstrated the association of many unexpected events, such as catheter-related complications, catheter-related blood stream infection, hypotension, hypothermia, tachycardia, and atrial fibrillation. Up to now, there is a lack of evidence regarding the timing of withholding CRRT. The furosemide stress test (FST) is a tool that is easy to use and has more availability. The investigators aimed to apply FST to evaluate renal recovery compared with standard treatment in critically ill patients undergoing CRRT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult 20 year of age or older
  • •Acute kidney injury (AKI) stage 3 according to Kidney Disease Improving Global Outcomes (KDIGO) classification with oliguria (urine <400 ml/day)
  • •Initiate CRRT in ICU (medical ICU, surgical ICU, cardiac care unit) for at least 48 hours (time for initiation and modality of CRRT can adjust by clinician)

排除标准

  • •Use any inotropic drug (norepinephrine, epinephrine, dopamine, dobutamine)
  • •Blood urea nitrogen (BUN) >80 mg/dL
  • •Serum K <3.5 or >5 mmol/L
  • •Arterial potential of Hydrogen (pH) <7.3
  • •Serum bicarbonate (HCO3) <15 mmol/L
  • •Urine volume <400 or >2,100 mL/day
  • •Urine creatinine clearance (CrCl) at 6 hours >20 mL/min
  • •Previous chronic kidney disease (CKD) stage 5 or estimated glomerular filtration rate (eGFR) <15 mL/min/1.73 m2
  • •Previous RRT within 14 days
  • •Kidney transplantation
  • •Obstructive etiology for AKI
  • •Toxin/drug that necessitates RRT
  • •Allergy to furosemide
  • •Moribund with expected death within 24 hours
  • •Pregnancy

研究组 & 干预措施

Protocol based-furosemide stress test

Experimental

Furosemide at 1.5 mg/kg intravenously

干预措施: Furosemide Injection (Drug)

Standard care

No Intervention

Standard CRRT care without furosemide use during treatment.

结局指标

主要结局

% of patients with Renal recovery

时间窗: 5 days

Free of RRT for at least 5 days

次要结局

  • % of complication(28 days)
  • Cost of RRT during hospitalization(28 days)
  • RRT free days(28 days)
  • % of patients with Mortality(28 days)
  • Ventilator-free day(28 days)
  • Day of Hospitalization(28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prit Kusirisin, MD

Principal investigator

Chiang Mai University

研究点 (1)

Loading locations...

相似试验

Effect of a Furosemide Stress Test-Guided Strategy... | 临床试验